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Abstract 
BACKGROUND: We optimized a quantitative amino acid method with pre-column 
derivatization, norvaline (nva) internal standard and reverse phase ultra-performance liquid 
chromatography by replacing the ultraviolet detector with a single quadrupole mass 
spectrometer (MSnva).   
METHOD: We used 13C15N isotopically labeled amino acid internal standards and a C18 
column with 1.6 m particles to optimize the chromatography and to confirm separation of 
isobaric compounds (MSlis). We compared the analytical performance of MSnva with MSlis 
and the original method (UVnva) with clinical samples. 
RESULTS: The chromatography time per sample of MSnva was 8 minutes, detection 
capabilities were <1 mol/L for most components, intermediate imprecisions at low 
concentrations were <10% and there was negligible carryover. MSnva was linear up to a total 
amino acid concentration in a sample of approximately 9 500 mol/L. The agreements 
between most individual amino acids were satisfactory compared to UVnva with the latter 
prone to outliers and suboptimal quantitation of urinary arginine, aspartate, glutamate and 
methionine. MSnva reliably detected argnininosuccinate, -alanine, citrulline and cysteine-s-
sulfate. 
CONCLUSION: MSnva resulted in a more than fivefold increase in operational efficiency 
with accurate detection of amino acids and metabolic intermediates in clinical samples. 
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1. Introduction. 
Quantitative amino acid analysis in plasma, urine and cerebrospinal fluid is central to the 
diagnosis and therapeutic management of inherited disorders of amino acid transport and 
metabolism. The reproducible ninhydrin post column derivatization method with 
spectrophotometric quantitation described by Stein and Moore (1, 2) has been the foundation 
of this analysis for nearly seven decades. Separation of the amino acids and related 
components was typically achieved with ion exchange liquid chromatography.  
The relatively recent introduction of reverse phase ultra-performance liquid 
chromatography (UPLC) and 6-aminoquinolyl-N-hydroxysuccinimidyl carbonate (AQC) (3) 
pre-column derivatization with norvaline (nva) as internal standard and ultraviolet (UV) 
detection has reduced the chromatography time from approximately 3 hours to 45 minutes 
per sample (4). Analysis of multiple amino acids in a single chromatography run remains a 
challenge due to their diverse chemical characteristics and the wide concentration ranges 
encountered in health and disease. Unpredictable interference can occur in some patients due 
to co-eluting exogenous compounds that also absorb in the UV spectrum (e.g. gabapentin and 
histidine; aminoglycosides and phenylalanine; aminocaproic acid (6)). The incomplete 
resolution of rarely occurring endogenous metabolites such as argininosuccinate with 
ethanolamine and 1-methyl histidine with cysteine-s-sulfate can also be problematical and 
repeat analyses with altered chromatographic conditions are required to resolve them (5).  
The throughput of a UV based method is therefore limited by the long chromatography times 
and the occasional need to repeat the analysis.  
Tandem mass spectrometry (MS/MS) with its inherent analytical specificity has the 
potential to avoid the deficiencies of UV based methods. MS/MS methods with or without a 
derivatization step and using either a single unlabeled or multiple isotopically labeled internal 
standards (lis) have been described (7, 8, 9). Isobaric compounds (leucine; isoleucine; 
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alloisoleucine; proline, -alanine; alanine; sarcosine, 1 and 2-methylhistidines and -, - and 
-butyrates) must be resolved either chromatographically or by a unique ion fragmentation 
pattern. 
Single quadrupole mass spectrometry (MS) detectors are more affordable, robust, and 
relatively simple to operate and is a promising detection technique with analytical properties 
intermediate between UV and MS/MS (10). The accurate mass detection may provide 
superior resolution to UV for co-eluting compounds with a different molecular mass, but the 
absence of ion fragments in this type of detector makes chromatographic separation of 
isobaric components paramount. A potential obstacle to MS detection is the lack of readily 
available isotopically labeled internal standards for each amino acid and related metabolite of 
interest in clinical specimens. 
Our aim was to optimize an established quantitative amino acid method by using MS 
detection, streamlining sample preparation and optimizing the chromatographic conditions. 
We retained the AQC derivatization procedure and also confirmed the suitability of nva as a 
single isotopically unlabeled internal standard.   
2. Materials and Methods 
As a proof of concept we swapped the UV detector of a commercial amino acid method 
(UVnva) with a MS detector while keeping the sample preparation and chromatographic 
conditions unchanged. In a stepwise manner we optimized the sample preparation and the 
chromatographic conditions while using isotopically labeled amino acids as internal 
standards (MSlis). To assess the suitability of nva as internal standard we compared this 
combination (MSnva) to MSlis as well as the original method with UV detection (UVnva). 
2.1 INSTRUMENTATION AND REAGENTS 
The following items were sourced from Waters (Waters Corporation, Milford, USA): 
MassTrak AAA Solution kit, an Acquity UPLC system with a binary solvent manager, 
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sample organizer and Empower data manager to perform UVnva (4). An Acquity QDa single 
quadrupole mass detector, a Cortecs UPLC BEH C18 column (1.6 m particles; 2.1 x 150 
mm), the neutral, acidic and basic amino acid standard solutions as well as allo-isoleucine, 
glutamine, nva and AQC reagents of the MassTrak AAA Solution kit were used for MSlis and 
MSnva. 
We expanded the range of amino acids in the commercial calibrators by adding 
argininosuccinate, cysteine-s-sulfate and homocitrulline (all obtained from Sigma Aldrich, St 
Louis, USA) to the mixture. Working calibrators were prepared at concentrations of 100; 200 
and 400 mol/L for all the components with the exception of cystine and cystathionine which 
were present at 50; 100 and 200 mol/L respectively. 13C and 15N isotopically labeled amino 
acids (Metabolomics Amino Acid Mix Standard) were obtained from Cambridge Isotope 
Laboratories (Tewksbury, MA, USA). The formic acid (Sigma Aldrich) and acetonitrile 
(Thermo Fisher, Waltham, USA) were MS-grade.  
Two levels of ClinChek amino acid quality control material (Recipe, Munich, 
Germany) were used to investigate imprecision. External quality proficiency material was 
obtained from the European Research Network for evaluation and improvement of 
screening, Diagnosis and treatment of Inherited disorders of Metabolism (ERNDIM, 
Netherlands) and the Australasian Society for Inborn Errors of Metabolism and the Human 
Genetics Society of Australasia (Sydney, Australia) education program. 
2.2 SAMPLE PREPERATION 
With UVnva the samples, calibrators and controls were prepared according to the 
manufacturer’s instructions (4). To improve workflow we investigated whether we could 
perform the penultimate heating step of the original UVnva after the final addition of 900 L 
water. In the optimized procedure we added 25L of either the calibrator, quality control 
material or sample and 25L water to 50L of 200 mol/L norvaline in 10% 5-
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sulfosalicylic acid.  Ten (10) L of supernatant obtained after centrifugation for 5 minutes at 
10000g was added into 70 L borate buffer in 0.2 mol/L NaOH. This was followed by adding 
20 L of the derivatization reagent and vortexing for 10 seconds. The volume was then made 
up to 1000 L with water, vortexed for 10 seconds after which the vials were placed in a 
55oC heating block for 10 min.  
2.3 OPTIMIZED CHROMATOGRAPHY AND MASS SPECTROMETRY CONDITIONS 
The column temperature was 55oC, flow rate 0.5 mL/min with the initial conditions of 99% 
mobile phase A (0.1% formic acid in water) and 1% mobile phase B (0.1% formic acid in 
acetonitrile). After 0.5 L of sample was injected a linear gradient (curve 6) was applied to 
87% A at 2 min, followed by 85% A at 4 min and 5% A at 5 min before returning to initial 
conditions from 7.6 to 8 min for re-equilibration. The ion source was a heated electrospray 
interface operated in the positive mode with the detector programmed to sample single ion 
reactions of selected atomic masses during timed intervals as depicted in Figure 1. The probe 
temperature was 600oC, the cone voltage 0.8 kV and the sampling rate 5 points/second. 
2.4 METHOD VALIDATION 
We characterized the detection capability, imprecision, carryover and linearity of the MSnva 
method. The detection capability was estimated by analyzing samples with concentrations of 
0, 1, 5 and 10 mol/L ten times each in one run, plotting the standard deviation (Sd) against 
concentration and then estimating by extrapolation the Sd blank and concentration where the 
imprecision was 20% (LOQ20%). Intermediate imprecision was determined over 20 days at 
two control levels. Carryover between samples was assessed by analyzing a blank 
immediately after a sample with high concentrations. Grossly elevated total amino acid 
concentrations in clinical samples may potentially exhaust the derivatizing reagent and result 
in non-linearity. We investigated this by analyzing 3 separate post mortem plasma samples, 
with extremely high total amino acid concentrations at several dilutions and then sequentially 
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discarding the highest value before repeating the statistical analysis. We tested the linearity of 
the high calibrator and also for selected amino acids that were anticipated to occur at higher 
levels in clinical samples (glycine, histidine, threonine and serine). 
We compared MSnva to the MSlis with 139 plasma, 100 urine and 97 cerebrospinal 
fluid (csf) samples submitted for routine amino acid analysis. After the optimization process 
was complete we compared MSnva with UVnva in another set of 80 plasma and 114 urine 
samples in order to standardize the time between sample preparation and analysis so that any 
artefactual conversion of glutamine to glutamate and arginine to ornithine was minimized. In 
our routine service delivery we use the UVnva as originally described (4) and if interference is 
suspected in a sample we follow this up with a second analysis under alternative 
chromatographic conditions (5). In the scatterplots and comparisons we only present results 
obtained with the original UVnva and not the final value obtained with the further analysis.  
We tested the ability of MSnva to deal with problematical samples by analyzing QAP and 
stored patient samples. The statistical analysis and non-parametric Passing Bablok 
regressions were performed with Analyse-it version 2.30 (Leeds, UK). Pearson’s parametric 
correlation was used to assess the relative strengths of the associations.  
3. Results 
The addition of water before the heating step resulted in a more efficient process and did not 
significantly change the median values for the 17 amino acids with labeled internal standards 
measured in 37 plasma and 28 urine samples (p > 0.05 in all instances). The total 
chromatographic run time of the optimized MSnva method was 8.0 minutes with resolution of 
isobaric components (Figure 1). Carryover between successive runs varied between 0.1 and 
0.5% for all amino acids tested and did not materially affect subsequent samples. The 
analytical performance characteristics of the MSnva method are presented in table 1. The 
detection limits for the individual amino acids were acceptable and only the Sdblank of serine 
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was above 1 mol/L which did not materially impact on the intended clinical utility. The 
intermediate imprecision was also appropriate for clinical purposes. The precision data is 
presented as the mean and Sd in Table 1 to allow an appreciation of the concentration ranges 
of the individual components in the quality control material. In summary the coefficient of 
variation was between 5% and 10% for the majority of individual amino acids. The MSnva 
linear range extended up to a total amino acid concentration of approximately 9500 mol/L 
(Supplementary Figure 1), which compared favorably with the 3500 mol/L reported for 
UVnva (4). We also confirmed the linearity of the high calibrator that contained 33 
components with individual concentrations of 400 mol/L and two with 200 mol/L each. 
We confirmed the individual linearity in pure solutions of glycine up to 5000 mol/L and of 
histidine, threonine and serine each up to 2000 mol/L. 
The scatter plots comparisons of plasma and urine samples assayed with MSnva, MSlis 
and UVnva for amino acids with an available isotopically labeled internal standard are 
depicted in Figures 2 and 3 as well as in Supplementary Figure 2. The comparisons between 
MSnva and UVnva for those without a labeled internal standard are shown in supplementary 
Figure 3. The regression statistics are summarized in Supplementary Table 1. With some 
notable exceptions the agreements between the methods were good with MSnva results 
acceptable for clinical use. In the group with labeled internal standards the agreement 
between the MSlis and MSnva was generally better than between MSnva and UVnva with R
2 
values and regression slopes closer to 1 and offsets closer to 0. There were suboptimal 
agreements between MSnva and UVnva with arginine, aspartate, and glutamate (Supplementary 
Figure 2) and with methionine (Figure 2) in urine samples. Due to concerns about the 
stability of asparagine, arginine and glutamine in stored samples we repeated the comparisons 
between MSnva and UVnva in a second sample set with the sample preparations and analyses 
performed on the same day – we present only the data of this second comparison in this 
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manuscript, although the comparisons were not materially different for any individual 
component. The external proficiency samples demonstrated differences in plasma glutamine 
and glutamate concentrations due to spontaneous conversion during storage, but the 
qualitative interpretation of the results were not affected (data not shown). 
In the group of amino acids without labeled internal standards poor agreements were 
noted between MSnva and UVnva with plasma alloisoleucine, -alanine and urine citrulline. A 
striking feature in this group was the number of fliers with an apparent very high UVnva result 
and a much lower MSnva result as shown in Figure 3 with urine isoleucine. We found the 
opposite in only one plasma -alanine sample where a low UVnva result occurred with an 
relatively elevated MSnva (Supplementary Figure 3). The comparisons of all the amino acids 
measured in csf samples are not shown, but the results for methionine and isoleucine that are 
illustrated in Figures 2 and 3 were representative for this sample type. The comparisons in csf 
were complicated by the low concentrations of most amino acids, but the same general 
pattern observed with plasma and urine samples was present, namely better agreement 
between MSnva and MSlis than between MSnva and UVnva.   
 Argininosuccinate, -alanine, 1-methylhistidine and cysteine-s-sulfate were 
accurately detected according to their atomic masses and the isobaric amino acids were 
chromatographically resolved with accurate quantitation by MSnva (Figure 1, Supplementary 
Figures 4 and 5). With UVnva argininosuccinate co-elutes with ethanolamine and a 
modification of with chromatographic conditions is required to separate them (5).  In 
instances where co-elution occurred with MSnva, i.e. with arginine, asparagine and 
phosphoethanolamine, the mass selectivity allowed unambiguous detection (Figure 1). 
Interferences that affected UVnva did not impact on MSnva (Supplementary Figures 5 and 6). 
4. Discussion 
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We describe a modified amino acid method with pre-column AQC derivatization, norvaline 
as a single unlabeled internal standard, reverse phase UPLC and single quadrupole mass 
spectrometry. The short chromatography time was a function of a C18-reverse phase column 
with smaller particles and of the MS detector with orthogonal atomic mass separation of co-
eluting non-isobaric components. The streamlined sample processing, short chromatography 
time and confident identification of multiple components in complex sample matrices 
resulted in a more than five-fold improvement in operational efficiency. Our routine UVnva 
service was nearing its maximum capacity and this motivated us to explore alternative 
options, such as MS, rather than purchasing a second dedicated amino acid analyzer system. 
The cost of a single quadrupole mass detector is approximately half that of a complete UPLC 
system with an UV detector, but instead of simply doubling the capacity MSnva has resulted 
in much larger gains and at a lesser cost. This was also achieved without increasing the 
instrument footprint, equipment maintenance or additional staff. 
The comparisons between MSnva and UVnva were suboptimal for urinary arginine, 
aspartate, glutamate and methionine (Supplementary Figure 2 and Figure 2). In each instance 
the scatter around the regression lines were greater than could be explained by their 
respective analytical imprecisions. With this group of amino acids the good agreement with 
the 13C15N isotopically labelled MSlis results led us to conclude that MSnva was more accurate 
than UVnva. This finding was expected due to the inherent analytical properties of mass 
spectrometry compared to UV detection. We could not identify a cause(s) for the outliers 
illustrated in Figure 3 and they persisted in selected cases even when we repeated the UVnva 
under alternative chromatographic conditions. The clinical impact of the poor agreement, 
which we attribute to the inherent limitations of UVnva, should however not be overstated as 
the affected amino acids are not pathognomonic and inaccurate measurement has not been a 
major issue to date with UVnva. To put this into context one should appreciate that only two 
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cases of a putative methionine malabsorption syndrome (OMIM % 250900) have been 
reported. The isolated instances of proportional bias (Supplementary Table 1) could be 
attributed to the small analytical range (<10 mol/L) and were mostly confined to csf with 
the exception of u-methionine and p-/u-glutamate. The effect on clinical interpretation and 
reference intervals are expected to be minimal, but this will be monitored prospectively. 
Our decision to persist with pre-column AQC derivatization and reverse phase 
chromatography was influenced by the proven efficiency of this modality to separate amino 
acids that range from acidic to basic and it also avoided the use of more complex column 
switching or MS unfriendly ion-paring chromatography. Derivatization to butyl esters was 
reported to destroy asparagine (7), but from our data this does not appear to occur with AQC. 
Although the use of a labeled internal standard for each analyte in the chromatogram have 
theoretical advantages and would be required for a reference method, we propose that a nva 
internal standard provides a pragmatic alternative. Isotopically labeled internal standards for 
each amino acid and related metabolites are not freely available, will result in added cost and 
may complicate the data analyses. Furthermore the sampling frequency of peaks will 
decrease and these closely eluting labeled components may contribute to ion suppression.  
The ability to rapidly and confidently identify clinically important metabolites such as 
cysteine-s-sulfate and argininosuccinate may potentially lead to improved clinical outcomes. 
With UVnva this required an additional set of chromatographic conditions (4, 5) and a second 
analysis which resulted in complex workflows and reliance on experienced analysts. With 
UVnva tyrosine elutes close to the N-hydroxy-succimide derivatization byproduct that absorbs 
in the UV-spectrum and can thus negatively affect accurate quantitation. Since MSnva relies 
on atomic mass it was not affected by this interference. The detection capability and extended 
linear range makes MSnva suitable for use with all types of biological samples and the 
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analytical sensitivity can be further improved, albeit at the expense of linear range, when one 
considers that only 0.5 L is injected onto the column. 
There MSnva chromatographic peak sizes of the calibrator, with all the components 
essentially at the same concentration, varied considerably (Figure 1). The ion counts of 
citrulline, ethanolamine, homocitrulline, phosphoethanolamine and taurine were markedly 
lower than those of ornithine, lysine and phenylalanine. In comparison with UVnva and the 
same calibrator, the peaks of ornithine and lysine were prominent, but those of the other 
components were average. This suggested to us that the derivatization efficiencies of 
ornithine and lysine were higher than average and that this variability may contribute to range 
of peak sizes, but could not fully explain it. The chromatograms of a MS/MS method without 
derivatization (9) had an even more variation in the ion count peaks and we speculated that 
variable ionization efficiencies of individual amino acids and other components may partly 
contribute to this peak size phenomenon. We did not detect a pattern in the physical 
properties such as pI, molecular size or presence of side chains that could have suggested 
what the underlying mechanism may be. Ion suppression can also theoretically contribute to 
variations of peak sizes, but we would have expected that at least one of the 17 labeled amino 
acids would have had a poor comparison between MSnva and MSlis if this was a common 
occurrence. Notably taurine and lysine were on opposite sides of the peak size spectrum and 
both had good agreements between MSnva and MSlis.  
The absence of performance and comparative data for homocystine is a potential 
limitation. Homocystine is present in the calibrators (Figure 1), but not in the commercial 
quality control materials and we therefore did not investigate the analytical performances for 
this analyte. The highest MSnva homocystine signals detected corresponded to concentrations 
of approximately 0.3 and 0.1 mol/L in plasma and urine samples respectively. We did not 
detect a homocystine signal in any sample with UVnva. Our historic practice is not to report 
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UVnva homocystine levels, but to monitor plasma methionine levels as a surrogate marker for 
homocystinuria (OMIM # 236200) and to measure total homocyst(e)ine as confirmatory test 
(11). Similarly serum vitamin B12 and urine methylmalonic acid would be measured in cases 
with suspected metabolic disorders (OMIM # 277400, # 275350) or vitamin deficiency states. 
 In our opinion MSnva is a superior analytical technique with improved analytical 
specificity, a short analysis time, and is well suited for routine clinical use. The introduction 
of MSnva has resulted in a marked operational efficiency improvement for a relatively modest 
capital investment. 
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Table1. Analytical performance characteristics of the UPLC single quadrupole mass spectrometry 
method with pre-column AQC derivatization and with norvaline as internal standard (MSnva). 
Amino acid aRetention bm/z  cSdblank dLoQ20% eQC1Mean eQC1Sd eQC2Mean eQC2Sd 
Histidine 2.169 163.6 0.31 0.99 72 5.7 291 16.7 
3-methylhistidine 2.217 170.6f 0.41 1.82 5.4 0.6 9.9 0.6 
1-methylhistidine 2.238 170.6f 0.32 1.01 4.8 0.9 7.3 1.2 
Hydroxyproline 2.223 302.1g 0.16 0.50 15 1.8 35 1.9 
Arginine 2.282 173.1 0.30 1.04 52 6.0 247 20.9 
Asparagine 2.278 303.1 0.29 0.90 51 3.7 246 11.4 
Taurine 2.344 296.1 0.15 0.42 33 2.7 118 8.8 
Argininosuccinate 2.350 231.2 0.32 1.84 na na na na 
Glutamine 2.361 317.1 0.13 0.35 289 14.1 640 28.5 
Serine 2.375 276.1 1.12 4.70 88 4.8 250 8.1 
Glycine 2.439 246.1 0.82 3.91 168 14.1 573 27.7 
Aspartate 2.475 304.1 0.29 0.67 10 0.4 81 3.4 
Citrulline 2.490 346.1 0.32 0.89 23 2.0 204 7.6 
Glutamate 2.536 318.1 0.24 0.60 159 13.8 263 22.9 
Threonine 2.612 290.1 0.34 0.91 107 5.5 195 9.4 
Alanine 2.713 260.1 0.81 2.12 356 18.9 611 24.4 
Ornithine 2.829 237.1 0.57 1.74 71 5.3 302 10.9 
Proline 2.846 286.1 0.18 0.46 205 10.9 425 15.6 
Cystine 3.009 291.2 0.08 0.32 14 1.62 20 1.9 
Lysine 3.031 244.1 0.20 0.84 152 9.2 231 9.8 
-aminobutyrate 3.067 274.1 0.07 0.20 15 0.9 61 2.8 
Tyrosine 3.465 352.1 0.05 0.14 58 5.5 232 7.8 
Methionine 3.718 320.1 0.08 0.23 34 2.2 58 3.5 
Valine 2.850 288.1 0.24 0.69 203 9.7 381 10.4 
Isoleucine 5.683 302.1g 0.10 0.31 68 4.2 116 3.4 
alloisoleucine 5.761 302.1g 0.10 0.28 na na na na 
Leucine 5.956 302.1g 0.24 0.92 186 9.0 294 11.1 
Phenylalanine 6.369 336.1 0.27 0.75 81 5.1 402 16.2 
Tryptophan 6.420 375.1 0.14 0.41 52 5.6 210 11.1 
 
a retention time in minutes, b Atomic mass (Dalton) to charge ratio, c Standard deviation of the blank 
(mol/L), d  Limit where a 20% coefficient of variation was achieved (mol/L), e Intermediate precision 
data collected over 20 days with two levels of quality control material are presented as the mean value 
and standard deviation in mol/L, f isobaric with m/z 170.6, g isobaric with m/z 302.1, na: not available. 
Please note that histidine, 1- and 2-methylhistidine, arginine and argininosuccinate are doubly charged 
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molecules. In source fragmentation may possibly explain the apparent loss of atomic mass of ornithine, 
cystine and lysine. 
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Figure legends. 
Figure 1. Total ion count chromatograms of the optimized MSnva method. 
 
The ion count intensities of each amino acid in the 200 mol/L calibrator (cystine and 
cystathionine 100mol/L) are depicted. After the addition of water and the internal standard 
the concentrations were diluted fourfold to 50 mol/L while the 200 mol/L norvaline is 
diluted twofold to 100 mol/L. The ion counts were obtained in single ion reaction 
monitoring mode with the atomic mass charge ratios of the derivatized amino acids indicated. 
The isobaric components are highlighted with the same color text boxes. In the bottom part of 
the figure the window between 2.1 and 3.1 minutes is expanded to facilitate peak 
identification. Cystathionine is separated into the L(+) and L(-) allocystathionine 
stereoisomers. PEA phosphoethanolamine.  
 
 
Figure 2. Comparison of plasma, urine and cerebrospinal fluid methionine measured with 
MSlis MSnva and UVnva 
 
MSnva single quadrupole mass spectrometry with norvaline as internal standard.  
MSlis single quadrupole mass spectrometry with 
13C15N labeled internal standard.  
UVnva  UV detction with norvaline as internal standard.  
a:  Passing Bablok regression offset,  
b:  Passing Bablok regression slope 
R2:  Pearson correlation coefficient.  
Solid symbols indicate the comparison between MSlis and MSnva.  
Open symbols indicate the comparison between UVnva and MSnva.  
Green indicates plasma, blue urine and black cerebrospinal fluid. 
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Figure 3. Comparison of isoleucine measured with MSlis MSnva and UVnva in plasma, urine 
and cerebrospinal fluid.  
 
MSnva single quadrupole mass spectrometry with norvaline as internal standard.  
MSlis single quadrupole mass spectrometry with 
13C15N labeled internal standard.  
UVnva  UV detction with norvaline as internal standard.  
a:  Passing Bablok regression offset,  
b:  Passing Bablok regression slope 
R2:  Pearson correlation coefficient.  
Solid symbols indicate the comparison between MSlis and MSnva.  
Open symbols indicate the comparison between UVnva and MSnva.  
Green indicates plasma, blue urine and black cerebrospinal fluid. 
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We modified a quantitative amino acid method with a norvaline internal standard (nva), pre-
column derivatization, reverse phase ultra-performance liquid chromatography and ultraviolet 
detection. The modified method retained the nva and derivatization steps but with a smaller 
particle C18 column and detection by single quadrupole mass spectrometry amino acids were 
accurately quantitated within 8 minutes. The new method increased capacity by more than 
fivefold and accurately detected problematical metabolites such as argininosuccinate. 
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